BioSymposium: Innovations in technologies – Implantables, Neurotech and Diagnostics

Advancements in medical technologies are transforming how we understand and treat complex health conditions, from neurological disorders to chronic diseases. With a rich history of innovation, including the pioneering cochlear implant, Australia is uniquely positioned to lead global efforts in integrating these groundbreaking technologies and emerging trends into scalable impactful commercialised solutions and patient care.

BioMelbourne Network’s first BioSymposium in 2025 will bring together thought leaders from research, industry, and clinical practice to spotlight advancements in implantables, neurostimulation, bioelectronics, and diagnostics. This full-day event will explore how these innovations are redefining the diagnosis and treatment of neurological and systemic disorders while tackling critical challenges in commercialisation, navigating regulatory pathways, attracting funding and translating research to impact patients worldwide.

The full-day program will delve into the latest breakthroughs in bioelectronic medicine, neuroimaging, and biomarker-driven diagnostics, alongside discussions on the role of implantable devices in improving the quality of life for those with chronic conditions.

Beyond highlighting the technologies themselves, the symposium will address the need for and foster collaboration across academia, industry, policymakers and government. Attendees will gain actionable insights into how Australia’s capabilities can lead global efforts, ensuring these technologies are innovative but also accessible, scalable, and transformative for the healthcare landscape. They will leave with actionable insights and connections that empower them to advance their work and drive the integration of these technologies into clinical and commercial settings.

Whether you’re a researcher, clinician, entrepreneur, or investor, this BioSymposium is a unique platform and your opportunity to engage with leading experts, network with key stakeholders, and be part of shaping the future of medtech.